The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit
- 30 June 1995
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 22 (1) , 13-17
- https://doi.org/10.1016/0732-8893(95)00050-k
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990Antimicrobial Agents and Chemotherapy, 1994
- Management of Infections Caused by Antibiotic-Resistant Streptococcus PneumoniaeNew England Journal of Medicine, 1994
- Antimicrobial susceptibility of Arcanobacterium haemolyticumAntimicrobial Agents and Chemotherapy, 1994
- Cephalosporins — Cefotaxime 10 years later, a major drug with continued useInfection, 1991
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methodsAntimicrobial Agents and Chemotherapy, 1988
- Chromosomal Cephalosporinases Responsible for Multiple Resistance to Newer β-Lactam AntibioticsAnnual Review of Microbiology, 1987
- Susceptibility of Campylobacter pyloridis to 20 antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- Antibacterial Activity of Desacetylcefotaxime Alone and in Combination with CefotaximeClinical Infectious Diseases, 1982
- Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of SynergyClinical Infectious Diseases, 1982